Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$44.3K Hold
85,804
﹤0.01% 250
2026
Q1
$54K Hold
85,804
﹤0.01% 251
2025
Q4
$75.3K Hold
85,804
﹤0.01% 262
2025
Q3
$117K Hold
85,804
0.01% 261
2025
Q2
$135K Hold
85,804
0.01% 227
2025
Q1
$227K Hold
85,804
0.02% 207
2024
Q4
$364K Hold
85,804
0.03% 174
2024
Q3
$285K Hold
85,804
0.02% 189
2024
Q2
$265K Hold
85,804
0.02% 177
2024
Q1
$347K Hold
85,804
0.03% 177
2023
Q4
$480K Hold
85,804
0.05% 105
2023
Q3
$457K Sell
85,804
-42,960
-33% -$349K 0.05% 107
2023
Q2
$1.21M Hold
128,764
0.13% 58
2023
Q1
$1.11M Sell
128,764
-42,961
-25% -$379K 0.13% 62
2022
Q4
$1.21M Sell
171,725
-385,921
-69% -$3.24M 0.14% 59
2022
Q3
$5.53M Hold
557,646
0.71% 18
2022
Q2
$3.98M Hold
557,646
0.47% 26
2022
Q1
$5.16M Sell
557,646
-181,368
-25% -$1.37M 0.49% 26
2021
Q4
$6.91M Buy
+739,014
New +$6.86M 0.81% 16

Other funds holding DCGO

BBR Partners's DCGO Position: Q2 2026 in Review

BBR Partners held its DocGo (DCGO) position steady in Q2 2026 at 85,804 shares worth $44.3K. The position accounts for ﹤0.01% of the portfolio, ranked #250.

BBR Partners first reported a position in DCGO in Q4 2021 and has held it in 19 quarters since. The position peaked at $6.91M in Q4 2021. 119 funds tracked by Wall St. Rank hold DCGO as of Q2 2026.

  • BBR Partners held 85,804 shares of DocGo worth $44.3K as of Q2 2026.
  • BBR Partners left its DocGo share count unchanged in Q2 2026.
  • DocGo made up ﹤0.01% of BBR Partners's portfolio in Q2 2026, its #250 holding.
  • BBR Partners first reported a position in DocGo in Q4 2021 and has held it in 19 quarters since.
  • BBR Partners's DocGo position peaked at $6.91M in Q4 2021.
  • 119 funds tracked by Wall St. Rank held DocGo as of Q2 2026.

Based on BBR Partners's 13F filing for Q2 2026, filed 11 Aug 2026.